Toshihiko Suzuki, MD, PhD
Assistant Professor
Professional Information
Biography
Dr. Toshihiko Suzuki plays a vital role in neonatal research and care, contributing to the understanding of embryological disease origins, respiratory dysfunction in neonates, and the therapeutic application of stem cells. His academic and clinical activities position him as a rising figure in the field of perinatal and regenerative medicine in Japan.
Specialization
Neonatology
Education
Ph.D. in Medicine: Nagoya University, 2020
M.D.
Research & Publications
"Intravenously delivered multilineage-differentiating stress enduring cells dampen excessive glutamate metabolism and microglial activation in experimental perinatal hypoxic ischemic encephalopathy" This study demonstrates the neuroprotective effects of Muse cells in a neonatal HIE model by reducing glutamate metabolism and microglial activation. "Safety and tolerability of a Muse cell-based product in neonatal hypoxic-ischemic encephalopathy with therapeutic hypothermia (SHIELD trial)" A clinical trial evaluating the safety of Muse cell-based therapy in newborns undergoing therapeutic hypothermia. "Mesenchymal stem/stromal cells stably transduced with an inhibitor of CC chemokine ligand 2 ameliorate bronchopulmonary dysplasia and pulmonary hypertension" This research explores stem cell therapy using CCL2-inhibited MSCs for treating neonatal lung diseases.